|
|
||||||||
Clinical Trial |
Twenty two adults with severe chronic airways obstruction--FEV1 from 14 to 57% of predicted--participated on two consecutive days in an open cross over comparison of inhalation of 2 mg terbutaline powder by Bricanyl Turbuhaler and 5 mg terbutaline by a conventional jet nebulizer (Pari Inhalierboy). All participants were domiciliary users of nebulized terbutaline previous to inclusion in this study. The mean (SD) maximal increase in FEV1 within the 60 minutes following inhalation by Turbuhaler and by Pari Inhalierboy was 27% (15%) and 28% (15%). The mean (SD) maximal increase in FVC was 30% (20%) and 29% (16%). The differences were not statistically significant. All participants were able to produce inspiratory flows high enough to use the Turbuhaler. The study suggests that it will be possible to replace the use of nebulizers with powder inhalations, as far as the bronchodilating effects are concerned.
This article has been cited by other articles:
![]() |
C. Brophy, J. Kastelik, E. Gardiner, and M. Greenstone Quality of life measurements and bronchodilator responsiveness in prescribing nebulizer therapy in COPD Chronic Respiratory Disease, February 1, 2008; 5(1): 13 - 18. [Abstract] [PDF] |
||||
![]() |
M. B. Dolovich, R. C. Ahrens, D. R. Hess, P. Anderson, R. Dhand, J. L. Rau, G. C. Smaldone, and G. Guyatt Device Selection and Outcomes of Aerosol Therapy: Evidence-Based Guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology Chest, January 1, 2005; 127(1): 335 - 371. [Abstract] [Full Text] [PDF] |
||||
![]() |
J Wright, D Brocklebank, and F Ram Inhaler devices for the treatment of asthma and chronic obstructive airways disease (COPD) Qual. Saf. Health Care, January 12, 2002; 11(4): 376 - 382. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Epstein, A. Maidenberg, D. Hallett, K. Khan, and K. R. Chapman Patient Handling of a Dry-Powder Inhaler in Clinical Practice Chest, November 1, 2001; 120(5): 1480 - 1484. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |